Last €65.45 EUR
Change Today -1.94 / -2.88%
Volume 34.2K
As of 1:55 PM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

draegerwerk ag - pref (DRW3) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/9/13 - €100.35
52 Week Low
07/15/14 - €63.90
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DRAEGERWERK AG - PREF (DRW3)

Related News

No related news articles were found.

draegerwerk ag - pref (DRW3) Related Businessweek News

No Related Businessweek News Found

draegerwerk ag - pref (DRW3) Details

Drägerwerk AG & Co. KGaA develops equipment and solutions in the fields of medical and safety technology. The company’s Medical division develops, produces, and markets system solutions, equipment, and services for the acute point of care process chain, including emergency care, peroopertive care, critical care, and perinatal care. It offers products for therapy, monitoring information management, and process support; and ventilation, anesthetics, vital signs ongoing surveillance, and accessories and consumables, as well as provides system products, such as integrated IT solutions for the operating room and gas management systems. This division’s product range covers anesthesia workstations, ventilation equipment, respiratory monitoring, warming therapy equipment, and patient monitoring equipment, as well as neonatal care for premature babies and newborns. The company’s Safety division develops, produces, and markets safety products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry, mining, and public sectors comprising fire departments, police, and disaster protection. Its product portfolio comprises stationary and mobile gas detection systems, personal protective equipment, professional diving systems, and alcohol and drug testing devices. This division also provides a range of training and services, as well as handles projects, such as fire training systems. The company serves customers in Germany and rest of Europe, the Americas, the Asia-Pacific, and internationally. Drägerwerk AG & Co. KGaA was founded in 1889 and is based in Lubeck, Germany.

13,210 Employees
Last Reported Date: 05/5/14
Founded in 1889

draegerwerk ag - pref (DRW3) Top Compensated Officers

Owner, Chairman of the Executive Board and Ch...
Total Annual Compensation: €824.0K
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €542.0K
Deputy Chairman of the Executive Board, Head ...
Total Annual Compensation: €793.3K
Head of Production & Logistics and Member of ...
Total Annual Compensation: €640.6K
Compensation as of Fiscal Year 2013.

draegerwerk ag - pref (DRW3) Key Developments

Dragerwerk AG & Co. KGaA Announces Earnings Results for the Second Quarter and First Half of 2014; Revises Earnings Guidance for the Fiscal Year 2014

Dragerwerk AG & Co. KGaA announced earnings results for the second quarter and first half of 2014. For the quarter, the company reported net sales fell by 1.2% to EUR 559.9 million against EUR 566.8 million a year ago. Group EBIT came in at EUR 15.0 million in the second quarter against EUR 39.4 million a year ago. For the period, the company reported net sales fell by 2.5%, increase of 1.2% net of currency effects. Total EBIT stood at EUR 34.0 million against EUR 79.2 million a year ago. For the fiscal year 2014, the company expects net sales growth of 2.0% to 4.0% until now: 3.0% to 6.0%. The gross margin is not likely to match the prior year's level.

Dräger Opens New Office and Design Centre in Canada

Dräger held the grand opening celebration of its new office and design centre in Mississauga, Ontario. Dräger's relationship with Canada goes back at least 100 years.

Dragerwerk AG & Co. KGaA Announces Earnings Results for the First Quarter Ended March 2014; Provides Earnings Guidance for the Full Year of 2014

Dragerwerk AG & Co. KGaA announced earnings results for the first quarter ended March 2014. For the quarter, the company reported net sales of EUR 513.2 million compared with EUR 533.8 million for the same period a year ago. EBIT was EUR 19.0 million compared with EUR 39.8 million for the same period a year ago. Earnings after income taxes was EUR 8.5 million or EUR 0.47 per share compared with EUR 22.6 million or EUR 1.27 per share for the same period a year ago. In the prior year's period, the company recorded a cash outflow of EUR 8.3 million. In the first quarter of 2014, the company had a cash inflow of EUR 25.1 million against cash outflow of EUR 8.3 million a year ago. This improvement is despite these substantially lower earnings after-income taxes, adjusted from non-cash positions, the decline of EUR 24.5 million to EUR 0.5 million. Net financial debt declined compared to year end, but is 19% up compared to the first quarter of 2013. For fiscal year 2014, Dräger expects net sales growth of between 3% and 6% and a Group EBIT margin of between 8.0% and 10.0%. This is based on the assumption of a stabilizing economy in Europe ­ particularly in South Europe ­ and North America, sustained market growth in developing countries and stable exchange rates. In view of the developments in the first quarter, it is expected that the EBIT margin will only be at the lower end of the range which is based on average exchange rates of 2013. On the basis of exchange rates of the first quarter for the full year a negative effect of up to 1.5 percentage points would weigh on the EBIT margin ­compared to the average rates of the previous year. For the full year, the company expects to continue good development of its cash flow situation.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRW3:GR €65.45 EUR -1.94

DRW3 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $43.75 USD -0.04
Dehaier Medical Systems Ltd $5.09 USD -0.07
Getinge AB kr167.60 SEK -0.80
Omnicell Inc $26.79 USD -0.61
STERIS Corp $50.43 USD -0.45
View Industry Companies

Industry Analysis


Industry Average

Valuation DRW3 Industry Range
Price/Earnings 10.9x
Price/Sales 0.5x
Price/Book 1.3x
Price/Cash Flow 4.1x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DRAEGERWERK AG - PREF, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at